Tobramycin 0.3% Eye Drops
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tobramycin 0.3% Eye Drops, covering 2014-10-29 to 2014-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. [Phase 3]